Behavioral therapy for active Crohn's disease
Part of Digestive system clinical trials.
This study tests whether a behavioral therapy program can help people with active Crohn's disease feel better when they start a new biologic medication. You'll get extra support to manage stress and symptoms while you and your doctor adjust your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have Crohn's disease confirmed by a colonoscopy and biopsy.
- You are currently having active Crohn's symptoms (like belly pain or diarrhea) and your tests show active inflammation.
- You are planning to start or have just started a biologic medication (such as adalimumab, infliximab, or risankizumab) within the next 6 weeks.
- You live in one of the 30+ states that allow a psychologist to treat you across state lines.
- You have not had surgery for Crohn's disease and are not pregnant or planning pregnancy in the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new targeted therapies for adults with moderate to severe Crohn's disease that hasn't improved with standard treatments. The goal is to see if these drugs can reduce inflammation and improve symptoms.
This study tests an oral medication called TAK-279 to see if it can safely reduce inflammation in the bowel for people with moderate to severe Crohn's disease who haven't had success with other treatments.
This study looks at whether adding a special liquid nutrition supplement (called partial enteral nutrition) to a new Crohn's disease treatment can help control symptoms better than the treatment alone. It may help reduce inflammation and improve your quality of life.
This study tests whether adding a diet and stress management program to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis feel better. It combines lifestyle changes with new medications to improve treatment outcomes.
This study tests whether a specially designed anti-inflammatory American diet can help control mild to moderate Crohn's Disease symptoms. Participants will follow a diet plan, with guidance from the research team, to see if it reduces inflammation and improves quality of life.
This study tests whether adding a special diet (called CDED) to a biologic medicine (infliximab or adalimumab) helps control Crohn's disease better than the medicine alone. It may reduce inflammation and improve symptoms.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.